These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11517429)

  • 1. Human immunodeficiency virus type 1 envelope-stimulated interleukin-2 production and survival of infected children with severe and mild clinical disease.
    Kuhn L; Meyers TM; Meddows-Taylor S; Simmank K; Sherman GG; Tiemessen CT
    J Infect Dis; 2001 Sep; 184(6):691-8. PubMed ID: 11517429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection.
    Wasik TJ; Jagodzinski PP; Hyjek EM; Wustner J; Trinchieri G; Lischner HW; Kozbor D
    J Immunol; 1997 Jun; 158(12):6029-36. PubMed ID: 9190958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS.
    Wasik TJ; Wierzbicki A; Whiteman VE; Trinchieri G; Lischner HW; Kozbor D
    Eur J Immunol; 2000 Jan; 30(1):117-27. PubMed ID: 10602033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 synthesis and IgE overproduction in children with perinatal human immunodeficiency virus-type 1 infection.
    de Martino M; Rossi ME; Azzari C; Chiarelli F; Galli L; Vierucci A
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):212-6. PubMed ID: 10071527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired interleukin-5 (IL-5) production by T cells as a prognostic marker of disease progression in human immunodeficiency virus type 1 (HIV-1)-infected children.
    Resino S; Sánchez-Ramón S; Bellón JM; Jiménez JL; Muñoz-Fernández MA
    Eur Cytokine Netw; 2001; 12(2):253-9. PubMed ID: 11399513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.
    Buseyne F; Scott-Algara D; Bellal N; Burgard M; Rouzioux C; Blanche S; Riviere Y
    J Infect Dis; 2005 Nov; 192(10):1781-6. PubMed ID: 16235177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.
    Clerici M; Wynn TA; Berzofsky JA; Blatt SP; Hendrix CW; Sher A; Coffman RL; Shearer GM
    J Clin Invest; 1994 Feb; 93(2):768-75. PubMed ID: 8113410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
    Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
    AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine patterns during progression to AIDS in children with perinatal HIV infection.
    Hyjek E; Lischner HW; Hyslop T; Bartkowiak J; Kubin M; Trinchieri G; Kozbor D
    J Immunol; 1995 Oct; 155(8):4060-71. PubMed ID: 7561117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.
    Ratto-Kim S; Garner RP; Kim JH; Jagodzinski LL; Michael NL; Paris R; Redfield RR; Birx DL
    J Infect Dis; 2004 Jun; 189(11):1988-95. PubMed ID: 15143464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.
    Marcelino JM; Nilsson C; Barroso H; Gomes P; Borrego P; Maltez F; Rosado L; Doroana M; Antunes F; Taveira N
    AIDS; 2008 Nov; 22(17):2257-65. PubMed ID: 18981765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
    Buseyne F; Le Chenadec J; Corre B; Porrot F; Burgard M; Rouzioux C; Blanche S; Mayaux MJ; Rivière Y
    J Infect Dis; 2002 Dec; 186(11):1589-96. PubMed ID: 12447734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-infected children.
    Kalish LA; McIntosh K; Read JS; Diaz C; Landesman SH; Pitt J; Rich KC; Shearer WT; Davenny K; Lew JF
    J Infect Dis; 1999 Nov; 180(5):1514-20. PubMed ID: 10515810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between HIV-Specific CD8 cell production of interferon- gamma and plasma levels of HIV RNA in perinatally infected pediatric populations.
    Borkowsky W; Zhan MX; Chen SH; Ilmet T; Kaul A; Chandwani S; Rigaud M; Essajee S; Gruber C; Freedman A; Krasinski K
    J Infect Dis; 2004 Aug; 190(4):722-6. PubMed ID: 15272400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission.
    Wasik TJ; Bratosiewicz J; Wierzbicki A; Whiteman VE; Rutstein RR; Starr SE; Douglas SD; Kaufman D; Sison AV; Polansky M; Lischner HW; Kozbor D
    J Immunol; 1999 Apr; 162(7):4355-64. PubMed ID: 10201969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
    De Rossi A; Walker AS; Klein N; De Forni D; King D; Gibb DM
    J Infect Dis; 2002 Aug; 186(3):312-20. PubMed ID: 12134227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.